Professional Documents
Culture Documents
Definition : Portal venous pressure > 7mmHg Clinical features & complications usually occur after pressure > 12mmHg
Clinical features
Investigations
*** diagnosis of portal HT often made on clinical grounds***
(supportive investigations) 1. Upper GI endoscopy for varices 2. Ultrasound 3. FBC -thrombocytopenia (due to hypersplenism) -leucopenia -anemia (due to bleeding) 4. Wedged hepatic venous pressure 5. CT/MRI
Case Study
Mr John, a 62 y/o accountant, has had a "drinking problem" throughout most of his adult life. He drinks 4 large bottles of beer each day. He was rushed to the emergency room with severe vomiting of bright red blood. The bleeding and vomiting started abruptly while he was eating some hard, dry French bread. On examination, he had a blood pressure of 60 mmHg / 30 mmHg.
Resuscitation and investigation Insert 2 large bore cannulae, one on each arm(16G) Draw 20ml of blood to test for
Cross match 2-4 units of whole blood/packed cells LFT, Clotting profile prothrombin time FBC BUSE & Creatinine Glucose level
Blood transfusion (whole blood, platelet, FPP, packed cell) should be given if:
Systolic BP < 100mmHg Persistant tachycardia (110/min) Significant postural hypotension Hb < 8/dl or haematocrit of 24%.
Interventional Therapy Endoscopic variceal ligation-preferred Endoscopic therapy if EVL difficulty **risk of perforation, bleeding/ulceration and stricture Balloon tamponade using SengstakenBlakemore tube if endoscopic treatment fails or unavailable.
Transjugular Intrahepatic Portosystemic Shunts (TIPS) is the treatment modality when bleeding is not responsive to endoscopic and pharmacological treatment.
Pharmacologic Therapy Terlipressin given as 2mg IV bolus and then 12mg 4-6 hourly until bleeding is controlled up to 24-48 hr Somatostatin infusion at 250ug/hr can be given after a bolus of 250ug IV and continued for 5 days Alternatively, octreotide can be infused at 2550 ug/hr for 5 days after a loading dose of 50ug.
Short-term antibiotic prophylaxis for 7 days irrespective of the type of haemorrhage (variceal or non-variceal) or the presence or absence of ascites Third generation cephalosporins (cefoperazone, ceftazidime) given intravenously or oral quinolones (norfloxacin/ciprofloxacin) are generally recommended.
Primary prophylaxis
40-80mg of Propanolol
*treatment with propanolol reduces variceal bleeding by 47%, death from bleeding
by 45% and overall mortality by 22% (Hayes PC, et al. Lancet 1990; 336:153 156)
Secondary Prophylaxis Start propanolol(if no contraindication) at 20mg and increase to 40-80mg TDS until resting HR is reduced by 25% to reduce portal venous pressure. Further endoscopic banding or injection sclerotherapy until varices are obliterated Referral for liver transplant
Variceal Bleeding
25-35% of the cirrhosis 30% of initial bleed is fatal 70%of survival will have recurrent bleed Key management -prevention
NEJM1988;319
20
Congestive Gastropathy
Long standing PHT causes chronic gastric congestion Recognizable at endoscopy multiple areas of punctate erythema (snake skin gastropathy) May cause bleeding from multiple sites (minor bleeding) causing anemia
supplements
Ascites
Pathological accumulation of fluid in the peritoneal cavity (normal people have a small amount of peritoneal fluid) Causes of ascites is based on Serum-ascitic albumin gradient (SAAG) which correlates directly with portal pressure.
Causes of Ascites
High gradient (SAAG = or > 1.1g/dL) Cirrhosis (Portal HPT)
Alcoholic hepatitis Cardiac failure Budd-Chiari syndrome Fulminant hepatic failure
Pathogenesis
Cirrhosis
Treatment
Transplant
Portal hypertension
TIPS
Arteriolar dilatation
Systemic vasoconstrictors
24
PVS, TIPS
Ascites
Management of Ascites
Investigational therapy
TIPS
Treatment
(1) Sodium and water restriction <100mmol/day (1.5 2g) no added salt diet Restrict water to 1 -1.5L/day (2) Diuretics Spironolactone 100 -400mg/day (caution: may cause painful gynaecomastia and hyperkalemia) Frusemide up to 160mg
If ascites is refractory (up to 3 5L daily is safe) Supported by an IV colloid such as human albumin (6-8g/L of ascites removed)
(4) Peritoneal venous Shunt (PVS) Rare, indicated in ascites resistant to conventional treatment Complications: infection, SVC thrombosis, pulmonary oedema, bleeding from oesophageal varices and DIVC.
(5) Transjugular intrahepatic portosystemic shunt (TIPSS)